NasdaqGS:ROIVBiotechs
Roivant Shelf Plan Raises Questions On Dilution And Pipeline Funding
Roivant Sciences (NasdaqGS:ROIV) has filed a shelf registration that would allow it to issue nearly $1 billion in new common shares.
The filing provides the company with flexibility to conduct future equity offerings when market conditions and funding needs align.
This potential issuance could affect shareholder dilution, capital raising plans, and Roivant's ability to fund future projects.
Roivant Sciences enters this development with its share price at $29.96 and very large multi-year...